ArticleClinical epigenetics2018

miR-29c plays a suppressive role in breast cancer by targeting the TIMP3/STAT1/FOXO1 pathway.

Wan Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.